Dr. Robert J. Siragusa is a dermatologist in Panama City,Florida. He graduated from New York Medical College in 1968 and has been in practice for 54 years.
New York Medical College, 1968
Male
1255320545
| Description | # of Times Performed | # of Patients | Average Charge ($) |
|---|---|---|---|
| Drainage of abscess | 65.0 | 63.0 | 170.0 |
| Tangential biopsy of single skin lesion | 1042.0 | 874.0 | 200.0 |
| Tangential biopsy of additional skin lesion | 328.0 | 251.0 | 100.0 |
| Punch biopsy of single skin lesion | 18.0 | 18.0 | 250.0 |
| Removal of up to and including 15 skin tags | 36.0 | 36.0 | 125.0 |
| Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | 46.0 | 41.0 | 320.0 |
| Removal of malignant growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs | 25.0 | 24.0 | 400.0 |
| Removal of malignant growth (1.1 to 2.0 centimeters) of the scalp, neck, hands, feet, or genitals | 22.0 | 19.0 | 315.0 |
| Injection of up to 7 skin growths | 137.0 | 123.0 | 95.0 |
| Injection of more than 7 skin growths | 46.0 | 32.0 | 110.0 |
| Destruction of skin growth | 1418.0 | 1052.0 | 120.0 |
| Destruction of 2-14 skin growths | 5197.0 | 840.0 | 35.0 |
| Destruction of 15 or more skin growths | 316.0 | 253.0 | 345.0 |
| Destruction of up to 14 skin growths | 476.0 | 415.0 | 145.0 |
| Destruction of 15 or more skin growths | 12.0 | 12.0 | 170.0 |
| Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs | 12.0 | 12.0 | 200.0 |
| Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | 92.0 | 80.0 | 250.0 |
| Destruction of malignant growth (2.1 to 3.0 centimeters) of trunk, arms, or legs | 23.0 | 23.0 | 295.0 |
| Destruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals | 76.0 | 67.0 | 328.02631579 |
| Destruction of malignant growth (2.1 to 3.0 centimeters) of scalp, neck, hands, feet, or genitals | 22.0 | 18.0 | 345.0 |
| Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | 66.0 | 58.0 | 250.0 |
| Destruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | 109.0 | 88.0 | 290.0 |
| Destruction of malignant growth (2.1 to 3.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | 11.0 | 11.0 | 350.0 |
| Biopsy of ear | 43.0 | 37.0 | 260.0 |
| Fungal culture (mold or yeast) of skin, hair, or nail | 15.0 | 14.0 | 16.0 |
| Pathology examination of tissue using a microscope, intermediate complexity | 1689.0 | 850.0 | 50.0 |
| Special stained specimen slides to identify organisms including interpretation and report | 62.0 | 51.0 | 100.0 |
| Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 93.0 | 75.0 | 41.720430108 |
| Application of light and light-sensitive drugs to aid destruction of premalignant skin growths, per session | 24.0 | 20.0 | 240.0 |
| Skin application of tar and ultraviolet B or petrolatum and ultraviolet B | 246.0 | 22.0 | 150.0 |
| New patient office or other outpatient visit, typically 10 minutes | 20.0 | 20.0 | 60.0 |
| New patient office or other outpatient visit, typically 20 minutes | 172.0 | 172.0 | 120.0 |
| New patient office or other outpatient visit, typically 30 minutes | 98.0 | 98.0 | 160.0 |
| Established patient office or other outpatient visit, typically 10 minutes | 357.0 | 315.0 | 85.0 |
| Established patient office or other outpatient visit, typically 15 minutes | 1874.0 | 1332.0 | 100.0 |
| Established patient office or other outpatient, visit typically 25 minutes | 181.0 | 146.0 | 135.0 |
| Subsequent nursing facility visit, typically 10 minutes per day | 28.0 | 21.0 | 105.0 |
| Subsequent nursing facility visit, typically 15 minutes per day | 33.0 | 27.0 | 165.0 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 574.0 | 203.0 | 10.0 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 35.0 | 25.0 | 447.85714286 |
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.